Wenjiang Zheng
Guangzhou University of Chinese Medicine
26 Papers
9 Citations
Wenjiang Zheng is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 3, co-authored 15 publications.
Chat about Author
Papers
Efficacy and safety of Chuankezhi injection in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis protocol.
Zhihui Zhou,Wenjiang Zheng,Ting Liang,Qian Yan,Chaoyuan Zhang,Huiting Huang,Xiaohong Liu,Xiaohan Ye +7 more
TL;DR: The efficacy and safety assessment of CKZ for COPD will be supported by this protocol, which will conduct a comprehensive and systematic literature search in 4 Chinese and 4 English databases and perform the meta-analysis with Stata 15 software.
2
[Meta-analysis and trial sequential analysis of modified Sangbaipi Decoction for treating acute exacerbation of chronic obstructive pulmonary disease].
TL;DR: In addition to conventional Western medicine treatment, modified Sangbaipi Decoction could improve the efficiency in treating acute exacerbation patients with chronic obstructive pulmonary disease, increase PaO2, and decrease PaCO2, with a high safety but no effect on pulmonary function.
1
Liver transcriptomics reveals microRNA features of the host response in a mouse model of dengue virus infection
Wenjiang Zheng,Ting Wang,Chengxin Liu,Qian Yan,Shaofeng Zhan,Geng Li,Xiaohong Liu,Yong Jiang +7 more
TL;DR: The miRNAs identified by sequencing, especially miR-484 may be the potential therapeutic targets for liver involvement in dengue patients which involves the regulation of vascular permeability and expression of inflammatory cytokines as discussed by the authors .
1
ITGAM-macrophage modulation as a potential strategy for treating neutrophilic Asthma: insights from bioinformatics analysis and in vivo experiments.
Qian Yan,Yujing Chen,Xinxin Zhang,Wenjiang Zheng,Xiaohong Liu,Huiting Huang,Qiong Liu,Shaofeng Zhan,Xiufang Huang +8 more
TL;DR: ITGAM was identified as a critical target to distinguish NA from healthy/non-NA individuals, which may provide a novel avenue to further uncover the mechanisms and therapy of NA.
1
Efficacy and safety of Sangbaipi Decoction in patients with acute exacerbation of chronic obstructive pulmonary disease: A protocol for systematic review and meta analysis.
TL;DR: The efficacy and safety assessment of Sangbaipi decoction for AECOPD will be supported by this protocol and the results will be submitted to a peer-reviewed journal.
1